📰 5 sources covering this story

AstraZeneca investors raise concerns over mega-merger talks

First covered 12 hrs ago · latest take 3 hrs ago. Compare how each outlet is covering it — and rate the sources you trust.

AstraZeneca investors raise concerns over mega-merger talks
AstraZeneca investors raise concerns over mega-merger talks
Shareholders question looming patent cliff and antitrust risks in potential $400bn tie-up with Bristol Myers Squibb
Evening Standard
Evening Standard🏁 first to report12 hrs ago
AstraZeneca in talks over £300bn mega-merger with US rival – reports
The move would mark one of the industry’s largest ever deals and create the world’s fourth largest pharmaceutical company.
Irish News
Irish News12 hrs ago
AstraZeneca in talks over £300bn mega-merger with US rival – reports
The move would mark one of the industry’s largest ever deals and create the world’s fourth largest pharmaceutical company.
The Independent
The Independent12 hrs ago
AstraZeneca in talks over £300bn mega-merger with US rival – reports
The move would mark one of the industry’s largest ever deals and create the world’s fourth largest pharmaceutical company.
Top rated outlets
Outlets are ranked once they have 3+ community ratings — be one of the first to rate.
🏆 Most trusted sources 2026 →
Scores come entirely from reader ratings — rate the sources you read to shape them. How it works →